Cannabichromene (CBC)
Definition: Cannabichromene, or CBC, is a non-intoxicating cannabinoid found in cannabis, usually in small amounts. Like THC and CBD, it comes from the same precursor, CBGA, and early lab research suggests it acts on the body’s CB2 receptors rather than the CB1 receptors that cause a high.
Does CBC Get You High?
Research so far says no. A 2019 study in the British Journal of Pharmacology found CBC activated CB2 receptors but not CB1 receptors in cell tests, which fits with it not being intoxicating.
What Is CBC Being Studied For?
Scientists are looking at CBC for inflammation, pain and other uses, but nearly all of the work is preclinical, meaning cell and animal studies. A 2024 review in the Journal of Pharmacology and Experimental Therapeutics describes its potential while noting that human evidence is still lacking. Treat health claims on CBC products with caution.
Where Do You Find CBC?
CBC shows up as a minor cannabinoid in many strains and in full-spectrum hemp extracts. Some brands now sell CBC isolates or CBC-forward blends, and it’s often mentioned as part of the entourage effect.
Related terms: Cannabinoids, CBG, CB2 Receptors, Entourage Effect
Sources: Udoh M, et al. Cannabichromene is a cannabinoid CB2 receptor agonist. British Journal of Pharmacology, 2019 (PMC); The potential of cannabichromene (CBC) as a therapeutic agent. Journal of Pharmacology and Experimental Therapeutics, 2024.

